TD Cowen raised the firm’s price target on Agilon Health (AGL) to $55 from $17 and keeps a Hold rating on the shares.The firm updated its model following better than expected Q1 results and while it remains early in the year, 1Q demonstrated operational momentum and better MA macro.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGL:
- Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/8/26?
- Agilon Health price target raised to $72 from $37.50 at Wells Fargo
- Agilon Health price target raised to $22 from $6.25 at BofA
- Agilon Health price target raised to $35 from $20 at Baird
- Agilon Health price target raised to $32 from $16 at Evercore ISI